Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,620.00    -70.00 (-1.23%)
Bid:
5,610.00
Ask:
5,630.00
Spread: 20.00 (0.357%)
Market Cap: £3.01b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

CMD and upgraded medium term targets

20 Mar 2025 07:00

RNS Number : 3755B
Cranswick PLC
20 March 2025
 

20 March 2025

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Capital Markets Day and upgraded medium term targets

 

Cranswick, a leading UK food producer, is today hosting a Capital Markets Day in London for analysts and institutional investors.

 

Presented by a selection of the Group's senior leaders, the event will provide an update on the Group's strategy, its successful compounding track record and how key strategic enablers will drive further growth.

 

Today's event will cover the following:

 

· Securing pig supply, driving competitive advantage and leveraging genetics capability

· Investing in fresh pork processing to add capacity and enhance automation

· Maximising the fresh poultry supply chain opportunity and growing poultry processing capacity

· Differentiated product portfolio and further premiumisation

· Strength and depth of customer relationships, including new long-term agreements

 

We will also outline upgraded medium term targets reflecting strengthening returns from disciplined capital allocation, as follows:

 

· Mid single digit organic revenue growth1

· ~7.5% adjusted operating margin2, increased from >6%

· Mid single digit adjusted EPS growth2 maintained

· Upper teens ROCE3, increased from mid-teens

· 4 maintained

· 90% free cash conversion5 maintained

 

For those unable to attend in person, a copy of the presentation and an audio recording will be made available after the event at www.cranswick.plc.uk.

 

Outlook

Robust demand for our core pork and poultry products has continued through the fourth quarter. The outlook for the current financial year ending 29 March 2025 remains in line with current market expectations6. No further material commentary on current trading and outlook will be provided at today's event.

 

Preliminary results

The Company's preliminary results announcement for the 52 weeks ending 29 March 2025 will be released on Tuesday 20 May 2025.

 

Adam Couch, CEO of Cranswick, commented:

"2025 marks Cranswick's 50th anniversary and today's Capital Markets Day event is a fantastic opportunity to reflect on our successful business model and strategy which have delivered strong, compound returns for our shareholders and compelling future growth opportunities.

 

"We are also announcing today more ambitious medium-term financial targets, reflecting the significant strategic progress we have made since first introducing these measures.

 

"Our relentless focus on the strengths of the business, which include industry leading investment, a clearly defined strategy, broadening product portfolio and unrivalled management team, will continue to support the future successful development of Cranswick over the long term."

 

 

1

2

3

 

4

5

 

6

Excludes the impact of M&A.

Excludes IAS 41 movement on biological assets, acquisition related amortisation and impairment of intangible assets.

Adjusted operating profit divided by the sum of average opening and closing net assets, net debt, pension surplus and deferred tax.

Net debt (including IFRS 16) divided by adjusted EBITDA.

Defined as the sum of net cash from operating activities less interest paid, non-growth capital expenditure, net IAS 41 valuation, lease capital and lease interest divided by adjusted profit for the year.

Market expectations for adjusted profit before tax as at 20 March 2025 range between £190.0m and £195.1m. The range reflects all published Broker analysis.

 

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Sodali & Co

+44 207 100 6451

Ben Foster / Louisa Henry / Flora Mackenzie

cranswick@sodali.com

 

 

Note to editors:

1. Cranswick is a leading and innovative supplier of premium, fresh and added-value food products. The business employs over 15,000 people and operates from 22 well-invested, highly efficient facilities in the UK. Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food. The business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a substantial export business. Results for the 53 weeks to 30 March 2024 showed revenue of £2,599.3m and profit before tax of £158.4m. For more information go to: www.cranswick.plc.uk

2. At Cranswick, it is second nature for us to protect and nurture our environment while supporting people and communities to thrive. Guided by our sustainability strategy, Second Nature, we have seamlessly integrated our sustainability commitments into the core of our business model, which in turn shapes our decision-making, culture, and actions. For more information on out Second Nature strategy, please visit: www.cranswick.plc.uk/sustainability

3. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAPDNFESSEFA
Date   Source Headline
2nd Aug 201212:13 pmRNSResult of AGM
2nd Aug 201212:08 pmRNSTotal Voting Rights
1st Aug 20127:00 amRNSInterim Management Statement
11th Jul 20122:20 pmRNSDividend Timetable
10th Jul 201210:26 amRNSHolding(s) in Company
9th Jul 201211:29 amRNSHolding(s) in Company
3rd Jul 201210:28 amRNSTotal Voting Rights
2nd Jul 20127:00 amRNSAcquisition
20th Jun 201210:08 amRNSDirector/PDMR Shareholding
18th Jun 201211:18 amRNSDirector/PDMR Shareholding
1st Jun 201210:26 amRNSTotal Voting Rights
21st May 20127:00 amRNSFinal Results
2nd Apr 201211:38 amRNSTotal Voting Rights
30th Mar 20127:00 amRNSFourth Quarter Trading Statement
2nd Feb 20122:38 pmRNSDirector/PDMR Shareholding
30th Jan 20124:07 pmRNSDirector/PDMR Shareholding
30th Jan 20124:06 pmRNSDirector/PDMR Shareholding
30th Jan 20124:03 pmRNSDirector/PDMR Shareholding
30th Jan 20127:00 amRNSQ3 Interim Management Statement
13th Jan 201212:18 pmRNSAdditional Listing
8th Dec 201111:36 amRNSDividend Timetable
14th Nov 20117:00 amRNSHalf Yearly Report
6th Oct 20117:00 amRNSTrading Statement
5th Oct 20119:46 amRNSBlocklisting Interim Review
23rd Sep 20116:11 pmRNSClose period repurchase agreement
23rd Sep 20116:04 pmRNSTransaction in Own Shares
6th Sep 20114:27 pmRNSDirector/PDMR Shareholding
6th Sep 20114:27 pmRNSDirector/PDMR Shareholding
22nd Aug 20114:22 pmRNSAdditional Listing
2nd Aug 20114:07 pmRNSResult of AGM
2nd Aug 201112:27 pmRNSTotal Voting Rights
28th Jul 20115:17 pmRNSDirector/PDMR Shareholding
27th Jul 20112:54 pmRNSHolding(s) in Company
26th Jul 20117:00 amRNSInterim Management Statement
30th Jun 20114:40 pmRNSTotal Voting Rights
24th May 20112:31 pmRNSDirector/PDMR Shareholding
23rd May 20114:05 pmRNSHolding(s) in Company
16th May 20117:00 amRNSFinal Results
4th May 20118:56 amRNSTotal Voting Rights
4th Apr 20117:00 amRNSFourth quarter trading statement
31st Mar 20114:05 pmRNSTotal Voting Rights
31st Mar 20114:03 pmRNSBlocklisting Interim Review
22nd Feb 20117:00 amRNSAppointment of Joint Broker
1st Feb 20117:00 amRNSInterim Management Statement
21st Jan 20113:55 pmRNSDirector/PDMR Shareholding
21st Jan 20113:54 pmRNSDirector/PDMR Shareholding
21st Jan 20113:53 pmRNSDirector/PDMR Shareholding
20th Jan 20111:58 pmRNSAdditional Listing
7th Jan 20114:58 pmRNSTotal Voting Rights
9th Dec 20107:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.